Palliative Care for Patients With Cancer in COVID-19 Era

JAMA Oncology

EMBARGOED FOR RELEASE: 11:10 A.M. (ET), THURSDAY, MAY 7, 2020

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.1938?guestAccessKey=97a1d890-8846-4c18-9af4-d313eca8f04a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050720

 

What The Viewpoint Says: The considerations and challenges affecting the palliative care specialty and delivery of palliative care in the COVID-19 era, as well as potential solutions, are discussed in this Viewpoint.

Authors: Ambereen K. Mehta, M.D., M.P.H., of the University of California, Los Angeles, in Santa Monica, is the corresponding author.

 

(doi:10.1001/jamaoncol.2020.1938)

Editor’s Note: The article includes conflict of interest disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.